← Leaderboards
Sarah Foster Adams
University Of New Mexico Health Scis Ctr
$2,438,558
Attributed
$2,438,558
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $361.7K · FY2019–25$500K$375K$250K$125K$0
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$2,438,558 · 1
By mechanism
R37$2,438,558 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of New Mexico Health Scis Ctr
Same institution · by research overlap
- Vojo P Deretic$34,270,796
- Cosette Marie Wheeler$16,558,570
- Charles Wiggins$27,351,744
- Christopher C Abbott$8,895,801
- Bryce C Chackerian$17,300,500
Others in their field
Other Emerging Leaders on “Ctla4 Blockade”
- Diwakar Davar · University Of Pittsburgh At Pittsburgh$3,640,421
- Sana D Karam · University Of Colorado Denver$3,185,899
- Christiane Querfeld · Beckman Research Institute/City Of Hope$2,825,258
- Evan Newell · Fred Hutchinson Cancer Research Center$2,763,230
- Taha Merghoub · Sloan-Kettering Inst Can Research$2,602,826
- Patrick Alexander Ott · Dana-Farber Cancer Inst$2,499,237
Research focus
Ctla4 BlockadeAdoptionCorrelative StudyClinical TrialsAntibody TherapyAreaClinical TranslationCombinatorialBlood SpecimenBlood TreatmentBrca1 GeneBrca1 MutationBrca2 MutationCancer BiologyAntibodiesCancer ModelCancer TherapyBiological MarkersCd8-Positive T-LymphocytesCell CycleCell DeathCellsClinical DataCtla4 Gene
Grant awards (7)
Mechanisms of Selective Therapeutic Synergy of PARP-inhibition and CTLA4 Blockade Engaged by Interferon-gamma in the Ovarian Tumor Microenvironment$351,908
R37 · FY2025 · CA · contact PI
Mechanisms of Selective Therapeutic Synergy of PARP-inhibition and CTLA4 Blockade Engaged by Interferon-gamma in the Ovarian Tumor Microenvironment$334,312
R37 · FY2024 · CA · contact PI
Mechanisms of selective therapeutic synergy of PARP-inhibition and CTLA4 blockade engaged by interferon-gamma in the ovarian tumor microenvironment$342,987
R37 · FY2023 · CA · contact PI
Mechanisms of selective therapeutic synergy of PARP-inhibition and CTLA4 blockade engaged by interferon-gamma in the ovarian tumor microenvironment$349,981
R37 · FY2022 · CA · contact PI
Mechanisms of selective therapeutic synergy of PARP-inhibition and CTLA4 blockade engaged by interferon-gamma in the ovarian tumor microenvironment$348,835
R37 · FY2021 · CA · contact PI
Mechanisms of selective therapeutic synergy of PARP-inhibition and CTLA4 blockade engaged by interferon-gamma in the ovarian tumor microenvironment$348,832
R37 · FY2020 · CA · contact PI
Mechanisms of selective therapeutic synergy of PARP-inhibition and CTLA4 blockade engaged by interferon-gamma in the ovarian tumor microenvironment$361,703
R37 · FY2019 · CA · contact PI